| Title |
Update on Clinical Trials of Losartan With and Without β-Blockers to Block Aneurysm Growth in Patients With Marfan Syndrome
|
|---|---|
| Published in |
JAMA Cardiology, July 2019
|
| DOI | 10.1001/jamacardio.2019.1176 |
| Pubmed ID | |
| Authors |
Marion A. Hofmann Bowman, Kim A. Eagle, Dianna M. Milewicz |
X Demographics
The data shown below were collected from the profiles of 88 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 26 | 30% |
| United Kingdom | 5 | 6% |
| Canada | 4 | 5% |
| Spain | 4 | 5% |
| Venezuela, Bolivarian Republic of | 3 | 3% |
| Brazil | 3 | 3% |
| Colombia | 2 | 2% |
| Australia | 1 | 1% |
| Mexico | 1 | 1% |
| Other | 5 | 6% |
| Unknown | 34 | 39% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 47 | 53% |
| Scientists | 26 | 30% |
| Practitioners (doctors, other healthcare professionals) | 11 | 13% |
| Science communicators (journalists, bloggers, editors) | 4 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 61 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 10 | 16% |
| Other | 5 | 8% |
| Student > Master | 5 | 8% |
| Student > Bachelor | 5 | 8% |
| Professor > Associate Professor | 4 | 7% |
| Other | 12 | 20% |
| Unknown | 20 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 44% |
| Biochemistry, Genetics and Molecular Biology | 6 | 10% |
| Nursing and Health Professions | 1 | 2% |
| Sports and Recreations | 1 | 2% |
| Immunology and Microbiology | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 25 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 49. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2022.
All research outputs
#855,479
of 25,410,626 outputs
Outputs from JAMA Cardiology
#812
of 2,145 outputs
Outputs of similar age
#17,771
of 343,683 outputs
Outputs of similar age from JAMA Cardiology
#26
of 61 outputs
Altmetric has tracked 25,410,626 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,145 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 95.0. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,683 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.